Clinical Trial Update: A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the specificity and sensitivity of 5-ALA fluorescence for detecting malignant brain tumors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Drugs mentioned

• 5-ALA fluorescence (5-aminolevulinic acid)

Snippet

Sponsor: Southern Illinois University | Conditions: Brain Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-11-30